Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) occurs more frequently in young (<50 years) non-Hispanic black and Hispanic/Latina women. It is considered the most aggressive subtype of breast cancer, although, recently, immune infiltrate has been associated with long-term survival, lower risk of death...

Full description

Bibliographic Details
Main Authors: Carlos Alexander Huertas-Caro, Mayra Alejandra Ramirez, Henry J. Gonzalez-Torres, María Carolina Sanabria-Salas, Silvia J. Serrano-Gómez
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.910976/full
_version_ 1811295896891031552
author Carlos Alexander Huertas-Caro
Mayra Alejandra Ramirez
Henry J. Gonzalez-Torres
Henry J. Gonzalez-Torres
María Carolina Sanabria-Salas
Silvia J. Serrano-Gómez
author_facet Carlos Alexander Huertas-Caro
Mayra Alejandra Ramirez
Henry J. Gonzalez-Torres
Henry J. Gonzalez-Torres
María Carolina Sanabria-Salas
Silvia J. Serrano-Gómez
author_sort Carlos Alexander Huertas-Caro
collection DOAJ
description Triple-negative breast cancer (TNBC) occurs more frequently in young (<50 years) non-Hispanic black and Hispanic/Latina women. It is considered the most aggressive subtype of breast cancer, although, recently, immune infiltrate has been associated with long-term survival, lower risk of death and recurrence, and response to neoadjuvant chemotherapy. The aim of this review was to evaluate the clinical impact of the immune infiltrate in TNBC by discussing whether its prognostic value varies across different populations. A comprehensive systematic search in databases such as PubMed and Web of Science was conducted to include papers focused on tumor-infiltrating lymphocytes (TILs) in TNBC in different population groups and that were published before January 2021. TNBC patients with higher levels of TILs had longer overall survival and disease-free survival times compared with TNBC patients with low TIL levels. Similar results were observed for CD4+, CD8+ TIL populations. On the other hand, patients with high TIL levels showed a higher rate of pathological complete response regardless of the population group (Asian, European, and American). These results altogether suggest that TIL subpopulations might have a prognostic role in TNBC, but the underlying mechanism needs to be elucidated. Although the prognosis value of TILs was not found different between the population groups analyzed in the revised literature, further studies including underrepresented populations with different genetic ancestries are still necessary to conclude in this regard.
first_indexed 2024-04-13T05:40:24Z
format Article
id doaj.art-809730699674440fb9e2b3dca7182447
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-13T05:40:24Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-809730699674440fb9e2b3dca71824472022-12-22T03:00:08ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-07-011210.3389/fonc.2022.910976910976Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast CancerCarlos Alexander Huertas-Caro0Mayra Alejandra Ramirez1Henry J. Gonzalez-Torres2Henry J. Gonzalez-Torres3María Carolina Sanabria-Salas4Silvia J. Serrano-Gómez5Grupo de investigación en biología del cáncer, Instituto Nacional de Cancerología, Bogotá, ColombiaGrupo de investigación en biología del cáncer, Instituto Nacional de Cancerología, Bogotá, ColombiaDoctorado en Ciencias Biomédicas, Universidad del Valle, Cali, ColombiaFacultad de Ciencias de la Salud, Universidad Simón Bolívar, Barranquilla, ColombiaGrupo de investigación en biología del cáncer, Instituto Nacional de Cancerología, Bogotá, ColombiaGrupo de apoyo y seguimiento para la investigación, Instituto Nacional de Cancerología, Bogotá, ColombiaTriple-negative breast cancer (TNBC) occurs more frequently in young (<50 years) non-Hispanic black and Hispanic/Latina women. It is considered the most aggressive subtype of breast cancer, although, recently, immune infiltrate has been associated with long-term survival, lower risk of death and recurrence, and response to neoadjuvant chemotherapy. The aim of this review was to evaluate the clinical impact of the immune infiltrate in TNBC by discussing whether its prognostic value varies across different populations. A comprehensive systematic search in databases such as PubMed and Web of Science was conducted to include papers focused on tumor-infiltrating lymphocytes (TILs) in TNBC in different population groups and that were published before January 2021. TNBC patients with higher levels of TILs had longer overall survival and disease-free survival times compared with TNBC patients with low TIL levels. Similar results were observed for CD4+, CD8+ TIL populations. On the other hand, patients with high TIL levels showed a higher rate of pathological complete response regardless of the population group (Asian, European, and American). These results altogether suggest that TIL subpopulations might have a prognostic role in TNBC, but the underlying mechanism needs to be elucidated. Although the prognosis value of TILs was not found different between the population groups analyzed in the revised literature, further studies including underrepresented populations with different genetic ancestries are still necessary to conclude in this regard.https://www.frontiersin.org/articles/10.3389/fonc.2022.910976/fulltriple-negative breast cancertumor-infiltrating lymphocytesprognosispredictivepopulation groups
spellingShingle Carlos Alexander Huertas-Caro
Mayra Alejandra Ramirez
Henry J. Gonzalez-Torres
Henry J. Gonzalez-Torres
María Carolina Sanabria-Salas
Silvia J. Serrano-Gómez
Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
Frontiers in Oncology
triple-negative breast cancer
tumor-infiltrating lymphocytes
prognosis
predictive
population groups
title Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
title_full Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
title_fullStr Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
title_full_unstemmed Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
title_short Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
title_sort immune lymphocyte infiltrate and its prognostic value in triple negative breast cancer
topic triple-negative breast cancer
tumor-infiltrating lymphocytes
prognosis
predictive
population groups
url https://www.frontiersin.org/articles/10.3389/fonc.2022.910976/full
work_keys_str_mv AT carlosalexanderhuertascaro immunelymphocyteinfiltrateanditsprognosticvalueintriplenegativebreastcancer
AT mayraalejandraramirez immunelymphocyteinfiltrateanditsprognosticvalueintriplenegativebreastcancer
AT henryjgonzaleztorres immunelymphocyteinfiltrateanditsprognosticvalueintriplenegativebreastcancer
AT henryjgonzaleztorres immunelymphocyteinfiltrateanditsprognosticvalueintriplenegativebreastcancer
AT mariacarolinasanabriasalas immunelymphocyteinfiltrateanditsprognosticvalueintriplenegativebreastcancer
AT silviajserranogomez immunelymphocyteinfiltrateanditsprognosticvalueintriplenegativebreastcancer